Investment Summary

Trustar Capital Invests In Taibang Biologic Group

On January 1, 2018, private equity firm Trustar Capital invested in life science company Taibang Biologic Group

Investment Highlights
  • This is Trustar Capital’s 3rd transaction in the Life Science sector.
  • This is Trustar Capital’s 14th transaction in China.

Investment Summary

Date 2018-01-01
Target Taibang Biologic Group
Sector Life Science
Investor(s) Trustar Capital
Deal Type Stake Purchase

Target

Taibang Biologic Group

Beijing, China
Taibang Biologic Group offers human plasma collection and medical production companies. Taibang Biologic Group was founded in 2002 and is based in Beijing, China.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

Trustar Capital

Hong Kong, China

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1978
PE ASSETS 8.7B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

Trustar Capital is the private equity arm of financial services/asset manager CITIC Group. Trustar Capital separates its private equity investment activity into three groups; China, Japan, and the US. In general, Trustar looks to invest in companies with 'strong franchises', with established brands and high barriers to entry. For US-based opportunities, the firm looks to leverage its connections in China. Broad areas of interest include niche manufacturing, consumer products, and business services. The Firm does not invest in start-ups or distressed businesses. Trustar Capital is based in Hong Kong.


DEAL STATS #
Overall 37 of 64
Sector: Life Science M&A 3 of 4
Type: Stake Purchase M&A Deals 4 of 6
Country: China M&A 14 of 31
Year: 2018 M&A 2 of 11
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-01-01 ByteDance

Beijing, China

ByteDance is an Internet technology company operating several machine learning-enabled content platforms. ByteDance was founded in 2012 and is based in Bejing, China.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-01-11 Axilone

Paris, France

Axilone is a manufacturer of plastic components for the make-up, fragrance and skincare markets: caps, jars, dispensing caps, galvanized and metallized collars and jars with strong added value through surface treatment. Axilone was founded in 1998 and is based in Paris, France.

Buy -